Pura Vida Investments, LLC Cyclacel Pharmaceuticals, Inc. Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.1 - $7.15 $473,164 - $554,611	-77,568 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.93 - $7.6 $146,803 - $188,145	-24,756 Reduced 24.19%	77,568 $237,000
Q4 2021 Feb 14, 2022	SELL	$6.04 - $8.03 $17,014 - $22,620	-2,817 Reduced 2.68%	102,324 $398,000
Q3 2021 Nov 15, 2021	SELL	$8.02 - $11.0 $418,587 - $574,123	-52,193 Reduced 33.17%	105,141 $554,000
Q2 2021 Aug 16, 2021	SELL	$7.59 - $10.48 $885,176 - $1.22 Million	-116,624 Reduced 42.57%	157,334 $931,000
Q1 2021 May 12, 2021	SELL	$6.86 - $9.24 $1.38 Million - $1.86 Million	-201,042 Reduced 42.32%	273,958 $1.95 Million
Q4 2020 Feb 16, 2021	BUY	$5.0 - $7.5 $2.38 Million - $3.56 Million	475,000 New	475,000 $3.71 Million

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $6.02M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.